HOME > BUSINESS
BUSINESS
- Vimpat Copies Hit Shelves at 35% of Originator Price as 10 Firms Flock to Market
December 5, 2025
- Keytruda Extends Japan Sales Lead to 26 Straight Months in November: Encise
December 5, 2025
- Meiji Pharma Takes Stake in Lyric Bio to Back Next-Gen IVIg Manufacturing
December 5, 2025
- PIII Win for Capricor’s DMD Cell Therapy Sets Stage for New FDA Try
December 5, 2025
- Novo Nordisk Launches Higher-Capacity Awiqli Pen in Japan
December 4, 2025
- Daiichi Sankyo Wins US Appeal in Seagen ADC Patent Dispute
December 4, 2025
- Vimpat Generics Win Added Use, Clearing Path for Full-Label Launch
December 4, 2025
- Alfresa, CMIC Ink Pact to Build Vaccination Support Platform
December 3, 2025
- Lundbeck Japan Plans to Double Workforce by 2028 as It Eyes 3 Drug Approvals
December 2, 2025
- Sawai Eyes Digital and Device Business as Next Growth Pillar after Generics
December 2, 2025
- Mochida Launches Mochi-Gel Cartilage Repair Device, a First for Japan
December 2, 2025
- Shionogi Completes Takeover of JT’s Pharma Business
December 2, 2025
- EMA Starts Review of Padcev-Keytruda for Perioperative Bladder Cancer
December 2, 2025
- Japan’s Prescription Drug Market to Near 12 Trillion Yen in FY2030: IQVIA
December 1, 2025
- Japan Dementia Drug Market to Hit 280 Billion Yen by 2040: Fuji Keizai
December 1, 2025
- JFCR, NEC, Taiho Launch AI-Driven R&D for Cancer Vaccines
December 1, 2025
- Eisai Files Subcutaneous Leqembi Autoinjector in Japan
December 1, 2025
- MSD to End Gardasil Sales in Japan as Use Shifts to 9-Valent HPV Shot
December 1, 2025
- Insmed Japan to Double Sales Force with Brensocatib Launch on the Horizon
November 28, 2025
- Chugai’s Market Cap Tops 14 Trillion Yen, Eyes Further Growth through “Co-Creation”: CEO
November 28, 2025
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
